Your search returned 1978 results.

Results
	1621.	New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. [electronic resource] by Sahebkar, Amirhossein Watts, Gerald F Producer: 20140318 In: Clinical therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1622.	Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials. [electronic resource] by Bays, Harold E Rosenson, Robert S Baccara-Dinet, Marie T Louie, Michael J Thompson, Desmond Hovingh, G Kees Producer: 20190114 In: Cardiovascular drugs and therapy vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1623.	Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study. [electronic resource] by Pek, Sharon Li Ting Dissanayake, Sanjaya Fong, Jessie Choi Wan Lin, Michelle Xueqin Chan, Eric Zit Liang Tang, Justin I-Shing Lee, Chee Wan Ong, Hean Yee Sum, Chee Fang Lim, Su Chi Tavintharan, Subramaniam Producer: 20190528 In: Atherosclerosis vol. 269 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1624.	Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis. [electronic resource] by Ding, Zufeng Liu, Shijie Wang, Xianwei Mathur, Pankaj Dai, Yao Theus, Sue Deng, Xiaoyan Fan, Yubo Mehta, Jawahar L Producer: 20170807 In: Antioxidants & redox signaling vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1625.	PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis. [electronic resource] by Langsted, Anne Nordestgaard, Børge G Benn, Marianne Tybjærg-Hansen, Anne Kamstrup, Pia R Producer: 20170620 In: The Journal of clinical endocrinology and metabolism vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1626.	Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS. [electronic resource] by Mondal, Kalyani Chakraborty, Pratip Kabir, Syed N Producer: 20181126 In: Biochemical and biophysical research communications vol. 503 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1627.	Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA. [electronic resource] by Bjune, Katrine Wierød, Lene Naderi, Soheil Producer: 20191014 In: Scientific reports vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1628.	Progress in finding pathogenic DNA copy number variations in dyslipidemia. [electronic resource] by Iacocca, Michael A Dron, Jacqueline S Hegele, Robert A Producer: 20200604 In: Current opinion in lipidology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1629.	Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. [electronic resource] by Yu, Qi Wang, Fang Meng, Xiaodong Gong, Yiren Wang, Yanli Xu, Cangbao Wang, Siwang Producer: 20181026 In: Molecular medicine reports vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1630.	Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies. [electronic resource] by Cho, Leslie Dent, Ricardo Stroes, Erik S G Stein, Evan A Sullivan, David Ruzza, Andrea Flower, Andrea Somaratne, Ransi Rosenson, Robert S Producer: 20190128 In: Cardiovascular drugs and therapy vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1631.	Real-world use of PCSK9 inhibitors: A single-center experience. [electronic resource] by Sarsam, Sinan Berry, Abeer Degheim, George Singh, Robby Zughaib, Marcel Producer: 20190606 In: The Journal of international medical research vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1632.	Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study. [electronic resource] by Nam, Chang-Wook Kim, Dong-Soo Li, Jianyong Baccara-Dinet, Marie T Li, Ivy Kim, Ji-Hyun Kim, Chong-Jin Producer: 20200420 In: The Korean journal of internal medicine vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1633.	Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. [electronic resource] by Zaid, Ahmed Roubtsova, Anna Essalmani, Rachid Marcinkiewicz, Jadwiga Chamberland, Ann Hamelin, Josée Tremblay, Michel Jacques, Hélène Jin, Weijun Davignon, Jean Seidah, Nabil G Prat, Annik Producer: 20080905 In: Hepatology (Baltimore, Md.) vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1634.	Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. [electronic resource] by Stein, Evan A Gipe, Dan Bergeron, Jean Gaudet, Daniel Weiss, Robert Dufour, Robert Wu, Richard Pordy, Robert Producer: 20120723 In: Lancet (London, England) vol. 380 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1635.	Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro. [electronic resource] by Schroeder, Christina I Swedberg, Joakim E Withka, Jane M Rosengren, K Johan Akcan, Muharrem Clayton, Daniel J Daly, Norelle L Cheneval, Olivier Borzilleri, Kris A Griffor, Matt Stock, Ingrid Colless, Barbara Walsh, Phillip Sunderland, Philip Reyes, Allan Dullea, Robert Ammirati, Mark Liu, Shenping McClure, Kim F Tu, Meihua Bhattacharya, Samit K Liras, Spiros Price, David A Craik, David J Producer: 20141016 In: Chemistry & biology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1636.	Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). [electronic resource] by Canuel, Maryssa Sun, Xiaowei Asselin, Marie-Claude Paramithiotis, Eustache Prat, Annik Seidah, Nabil G Producer: 20131209 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1637.	CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism. [electronic resource] by Dong, Bin Singh, Amar Bahadur Fung, Chin Kan, Kelvin Liu, Jingwen Producer: 20150330 In: Atherosclerosis vol. 235 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1638.	PCSK9 inhibitors- A new age in lipid management? [electronic resource] by Grant, Peter J Producer: 20180921 In: Diabetes & vascular disease research vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1639.	Modulation of cholesterol transport by maternal hypercholesterolemia in human full-term placenta. [electronic resource] by Zhang, Ran Dong, Shan Ma, Wei-Wei Cai, Xue-Ping Le, Zhi-Yin Xiao, Rong Zhou, Qi Yu, Huan-Ling Producer: 20170828 In: PloS one vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1640.	The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response. [electronic resource] by Ooi, Teik Chye Krysa, Jacqueline A Chaker, Seham Abujrad, Hussein Mayne, Janice Henry, Kathy Cousins, Marion Raymond, Angela Favreau, Colette Taljaard, Monica Chrétien, Michel Mbikay, Majambu Proctor, Spencer D Vine, Donna F Producer: 20171012 In: The Journal of clinical endocrinology and metabolism vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.